Quantum Genomics Societe Anonyme (FR:ALQGC)
:ALQGC
Total Valuation
Quantum Genomics Societe Anonyme has a market cap or net worth of €5.01M. The enterprise value is €7.34M.
Market Cap€5.01M
Enterprise Value€7.34M
Share Statistics
Quantum Genomics Societe Anonyme has 69,709,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding69,709,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Quantum Genomics Societe Anonyme’s return on equity (ROE) is 3.62 and return on invested capital (ROIC) is -153.05%.
Return on Equity (ROE)3.62
Return on Assets (ROA)-25.07
Return on Invested Capital (ROIC)-153.05%
Return on Capital Employed (ROCE)-8.06
Revenue Per Employee3.33
Profits Per Employee-2.96M
Employee Count3
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Quantum Genomics Societe Anonyme is ―. Quantum Genomics Societe Anonyme’s PEG ratio is -0.01.
PE Ratio―
PS Ratio502592.05
PB Ratio-2.05
Price to Fair Value-2.05
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-0.01
Income Statement
In the last 12 months, Quantum Genomics Societe Anonyme had revenue of 10.00 and earned -8.89M in profits. Earnings per share was -0.13.
Revenue10.00
Gross Profit-1.15M
Operating Income-1.47M
Pretax Income-8.89M
Net Income-8.89M
EBITDA-1.47M
Earnings Per Share (EPS)-0.13
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Quantum Genomics Societe Anonyme pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.74
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)0.00
Important Dates
Quantum Genomics Societe Anonyme upcoming earnings date is Mar 28, 2024, TBA (Confirmed).
Last Earnings DateOct 5, 2023
Next Earnings DateMar 28, 2024
Ex-Dividend Date―
Financial Position
Quantum Genomics Societe Anonyme as a current ratio of 2.05, with Debt / Equity ratio of -107.44%
Current Ratio2.05
Quick Ratio2.05
Debt to Market Cap0.68
Net Debt to EBITDA-1.59
Interest Coverage Ratio-53.51
Taxes
In the past 12 months, Quantum Genomics Societe Anonyme has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Quantum Genomics Societe Anonyme EV to EBITDA ratio is -5.01, with an EV/FCF ratio of 0.00.
EV to Sales736.35K
EV to EBITDA-5.01
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Quantum Genomics Societe Anonyme has €301.02K in cash and marketable securities with €2.64M in debt, giving a net cash position of -€2.34M billion.
Cash & Marketable Securities€301.02K
Total Debt€2.64M
Net Cash-€2.34M
Net Cash Per Share-€0.03
Tangible Book Value Per Share-€0.04
Margins
Gross margin is -11453070.00%, with operating margin of -14728350.00%, and net profit margin of -88926030.00%.
Gross Margin-11453070.00%
Operating Margin-14728350.00%
Pretax Margin-88926030.00%
Net Profit Margin-88926030.00%
EBITDA Margin-14702370.00%
EBIT Margin-14728340.00%
Analyst Forecast
The average price target for Quantum Genomics Societe Anonyme is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―